Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Amicus Therapeutics Inc. buy UBS Group AG

Amicus Therapeutics Inc.
Start price
€8.60
10.05.24 / 50%
Target price
€17.63
10.05.25
Performance (%)
-37.79%
End price
€5.35
11.05.25
Summary
This prediction ended on 11.05.25 with a price of €5.35. The BUY prediction by UBS_Group_AG for Amicus Therapeutics Inc. performed very badly with a performance of -37.79%. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Amicus Therapeutics Inc. 10.843% 10.843% -1.075%
iShares Core DAX® -0.793% 4.201% 19.951%
iShares Nasdaq 100 -2.376% 0.857% 4.704%
iShares Nikkei 225® -2.701% -0.147% 12.609%
iShares S&P 500 -1.689% 1.244% 3.144%

Comments by UBS_Group_AG for this prediction

In the thread Amicus Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -37.79%
Target price 17.632
Change
Ends at 10.05.25

Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at UBS Group AG from $20.00 to $19.00. They now have a "buy" rating on the stock.
Ratings data for FOLD provided by MarketBeat

UBS Group AG 
0
Report Share
10.05.24
In the thread Trading Amicus Therapeutics Inc.
Prediction Buy
Perf. (%) -37.79%
Target price 17.632
Change
Ends at 10.05.25

Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten

UBS Group AG 
0
Report Share
11.05.25

Stopped prediction by UBS_Group_AG for Amicus Therapeutics Inc.

buy
Amicus Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.00
02.03.23
€16.05
02.03.24
0.83%
03.03.24

UBS Group AG 
02.03.23 50%